Cite
Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune Hepatitis
MLA
Tom M. Nanga, et al. Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune Hepatitis. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e8866ecc7df686c20d23474ed2785f7&authtype=sso&custid=ns315887.
APA
Tom M. Nanga, Jean‐Baptiste Woillard, Annick Rousseau, Pierre Marquet, & Aurélie Prémaud. (2021). Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune Hepatitis.
Chicago
Tom M. Nanga, Jean‐Baptiste Woillard, Annick Rousseau, Pierre Marquet, and Aurélie Prémaud. 2021. “Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune Hepatitis,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e8866ecc7df686c20d23474ed2785f7&authtype=sso&custid=ns315887.